Environmental Health Economic Analysis Annotated Bibliography
Details
Review Cost analysis (CA)Authors
Weiss B
Journal
NeuroToxicology
Summary
This review discussed factors to consider for monetizing the economic costs associated with declining capacities in the context of manganese-induced neurodegenerative diseases (e.g., Parkinson's disease). The author suggested that slight elevations in airborne manganese may produce a small but economically significant shift to an earlier onset of neurodegenerative diseases, such as Parkinson’s disease.
Population
Not available
Health Outcomes
- Reviewed publications that examined — neurological/cognitive outcomes (Parkinson's disease, other neurodegenerative diseases (Manganism))
Environmental Agents
List of Environmental Agents:
- Reviewed publications that examined — metal (manganese)
Source of Environmental Agents:
- Reviewed publications that examined — inhaled manganese (hazardous air pollutant)
Economic Evaluation / Methods and Source
Type:
- Cost analysis (CA)
Cost Measured:
- Reviewed publications that examined — costs associated with Parkinson's disease, such as annual medical costs
Potential Cost Measures:
- Costs of institutionalization
- costs related to remedial care and/or education
- decline in functional capacity
Benefits Measures: (Not available)
Potential Benefits: (Not available)
Location: (Not available)
Models Used: (Not available)
Methods Used:
- The author reviewed previous literature to analyze how manganese neurotoxicity elevates Parkinson's risk and explored the influence of aging along with the economic implications of these risks.
Sources Used:
- Rate of cell death in Parkinsonism indicates active neuropathological process (McGeer et al., 1988); Ageing and Parkinson's disease: substantia nigra regional selectivity (Fearnley and Lees, 1991); additional sources cited in publication
Economic Evaluation / Methods and Source
Citation:
- Weiss B. 2006. Economic implications of manganese neurotoxicity. NeuroToxicology.
- Pubmed
- DOI: (Not available)
NIEHS Funding:
- P01ES001247
- P50ES001247
- P30ES001247
Other Funding: (Not available)
to Top